May 23, 2018
2018 Market Spotlight for Insomnia - Belsomra is Forecasted to Overtake Ambien to Have the Highest Revenues, Peaking in 2021
May 23, 2018
HETLIOZ® (tasimelteon) Effective in Treating Jet Lag during Transatlantic Travel
Apr 17, 2018
Clinical Trial Begins For Promising New Post-Menopausal Therapy Treating Vasomotor Symptoms
Mar 12, 2018
Philips celebrates World Sleep Day early with the release of its annual global sleep survey results, overnight concert experience
Mar 07, 2018
Eisai and Purdue Pharma Announce Positive Topline Results From Key Clinical Studies of Lemborexant Including First-Ever Phase 3 Head-to-Head Superiority Comparison Versus Zolpidem ER in Patients With Sleep Disorder
Jan 17, 2018
Neurim Pharmaceuticals' New Paediatric Prolonged-Release Melatonin ("PedPRM") to Be Marketed by BIOCODEX Oy in Finland
Nov 24, 2017
Global Insomnia Therapeutics Market, 2025 - Market is Expected to Reach USD 3.45 Billion
Nov 01, 2017
Insomnia Therapeutics Market Size Worth $3.45 Billion by 2025: Grand View Research, Inc.
Oct 10, 2017
Positive Phase III Results for Neurim Pharmaceuticals' Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder (ASD) Presented at the World Sleep Congress in Prague
Sep 28, 2017
Cohen Veterans Bioscience Partners to Build Wellness Platform for Brain Disorders
Sep 25, 2017
Neurim Pharmaceuticals' New Paediatric Prolonged-Release Melatonin ('PedPRM') to be Marketed by Flynn Pharma in UK and Ireland
Sep 14, 2017
Pear Therapeutics Obtains FDA Clearance of the First Prescription Digital Therapeutic to Treat Disease
Jun 15, 2017
Neurotech Company Rythm Launches Dreem, A Completely New Category of Product That Enhances Sleep
Jun 06, 2017
The Global Sleep Wake Disorders Market is Expected to Grow With the CAGR of 16.8% (Approx.) During the Forecast Period 2016-2023: Occams Business Research & Consulting
Jun 06, 2017
Sleep Easily Announces Father's Day Special on all Products